CytoDyn (QB) Stock Price - CYDY

2.8801
0.1001 (3.6%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.1001 3.6% 2.8801 2.74 2.99 2.99 2.78 16:59:04
Bid Price Ask Price Spread Spread % News
2.85 2.91 0.06 2.06% 3 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,916 8,108,017 $ 2.8582 $ 23,173,934 5,653,327 0.261 - 3.50
Last Trade Time Type Quantity Stock Price Currency
16:01:02 formt 1,000 $ 2.899 USD

CytoDyn (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.38B 480.16M $ -50.15M - - 331.64M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.44M $ - 0.00% - -

more financials information »

CytoDyn (QB) News

Loading Messages....

Latest CYDY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.343.442.002.6315,105,318-0.4599-13.77%
1 Month0.9353.500.812.339,492,7471.95208.03%
3 Months1.063.500.791.825,881,6961.82171.71%
6 Months0.38753.500.2611.513,680,9852.49643.25%
1 Year0.4993.500.2611.382,075,3432.38477.17%
3 Years0.603.500.05521.22871,0212.28380.02%
5 Years0.8453.500.05521.17603,9882.04240.84%

CytoDyn (QB) Description

CytoDyn is a publicly traded biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses. CytoDyn's lead product candidate, PRO 140, has the potential to drive groundbreaking advancements in developing the next generation of HIV treatments.


Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.